# Selegiline in Treatment of Cocaine Dependence - 2

> **NCT00000188** · PHASE2 · COMPLETED · sponsor: **University of Pennsylvania** · enrollment: 50 (actual)

## Conditions studied

- Cocaine-Related Disorders

## Interventions

- **DRUG:** Selegiline

## Key facts

- **NCT ID:** NCT00000188
- **Lead sponsor:** University of Pennsylvania
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1994-09
- **Primary completion:** 1995-10
- **Final completion:** 1995-10
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2015-05-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00000188

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00000188, "Selegiline in Treatment of Cocaine Dependence - 2". Retrieved via AI Analytics 2026-09-17 from https://api.ai-analytics.org/clinical/NCT00000188. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*